Dalton Kieran, Connery Ciarán, Murphy Kevin D, O'Neill David
Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Ireland.
Explor Res Clin Soc Pharm. 2022 Mar 20;5:100127. doi: 10.1016/j.rcsop.2022.100127. eCollection 2022 Mar.
The Falsified Medicines Directive (FMD) was implemented to minimise the circulation of falsified medicines in the legal pharmaceutical supply chain. Whilst pharmacists are involved in the final step of the FMD requirements with the decommissioning of medicines at the point of supply to patients, limited research has been conducted to investigate the impact of fulfilling these requirements on the relevant stakeholders.
To examine community pharmacists' views on how the FMD has affected their practice.
An online survey was disseminated via email in June 2020 to pharmacists in Ireland ( = 4727), who were invited to participate if practising full time or part time in community pharmacies. Quantitative data were captured through multiple option and Likert-scale questions, and analysed using descriptive and inferential statistics. Qualitative data were captured by use of a free-text box, with the open comments analysed thematically.
In total, 618 valid responses were received (13.1% response rate). Most perceived that FMD requirements increased waiting times for patients (82%) and reduced time interacting with patients (65%). Only 28% agreed/strongly agreed that the . In the open comments, the need for medicine authentication was acknowledged, but it was believed that this should be the wholesalers' responsibility, not pharmacists' responsibility. The additional step of medicines decommissioning was viewed as a time-consuming distraction to clinical checks that increased the risk for error. Pharmacists complained that they were not remunerated for the lost staff productivity or the additional software and equipment costs. Many pharmacists felt that the increased workload was disproportionate to the small risk of patients receiving falsified medicines.
Key stakeholder engagement is required to optimise the implementation and integration of the FMD procedures into community pharmacy practice with minimal impact on dispensing and without compromising patient care.
《假药指令》（FMD）的实施旨在尽量减少假药在合法药品供应链中的流通。虽然药剂师参与了FMD要求的最后一步，即在向患者供应药品时停用药品，但针对履行这些要求对相关利益相关者的影响所开展的研究有限。
探讨社区药剂师对FMD如何影响其工作的看法。
2020年6月通过电子邮件向爱尔兰的药剂师（n = 4727）开展了一项在线调查，邀请全职或兼职在社区药房工作的药剂师参与。通过多项选择题和李克特量表问题收集定量数据，并使用描述性和推断性统计进行分析。通过自由文本框收集定性数据，对开放式评论进行主题分析。
共收到618份有效回复（回复率为13.1%）。大多数人认为FMD要求增加了患者的等待时间（82%），并减少了与患者互动的时间（65%）。只有28%的人同意/强烈同意……在开放式评论中，认可了药品认证的必要性，但认为这应该是批发商的责任，而非药剂师的责任。药品停用这一额外步骤被视为对临床检查的一种耗时干扰，增加了出错风险。药剂师抱怨称，他们没有因员工生产力损失以及额外的软件和设备成本而获得报酬。许多药剂师认为，工作量的增加与患者收到假药的小风险不成比例。
需要关键利益相关者的参与，以优化FMD程序在社区药房实践中的实施和整合，使其对配药的影响最小，且不影响患者护理。
